Documentaries
Video by AsapSCIENCE. Watch on YouTube ↗
Summary
In under three minutes, the YouTube science channel AsapSCIENCE covers what LSD (lysergic acid diethylamide) does inside the brain and body, from its accidental discovery in 1943 to the receptor-level mechanics behind a trip, plus a quick look at therapy research and known risks. It is a fast primer rather than a deep dive, a starting point on LSD rather than a full picture.
The video traces LSD to its first synthesis in 1938, from a fungus that grows on rye, and to chemist Albert Hofmann, credited with discovering its psychoactive effects in 1943 after accidentally absorbing a small amount. Research continued through the 1950s and 60s, then largely stopped once LSD became a Schedule I substance in the US as recreational use spread, which the video offers as the reason interest in its mechanisms and therapeutic potential is only now returning.
LSD interacts with several receptor types, including dopamine, adrenergic, and glutamate receptors, but the video's focus is the serotonin 5-HT2A receptor. It describes LSD binding at an unusual angle that causes the receptor to fold over the molecule, trapping it and keeping it firing, which the video links to hallucination. The body reportedly clears the drug by pulling the receptor into the cell, a process that can take 12 or more hours and may help explain why the effects last so long. Newer neuroimaging work cited in the video found that LSD changes how brain regions communicate, particularly in the visual cortex, possibly explaining vivid, complex hallucinations. Researchers also observed decreased blood flow in the default mode network, linked in the video to ego dissolution, described as "a feeling where the boundary that separates you from the rest of the world dissolves." For more on how psychedelics reshape brain activity, see Psylopedia's overview of psychedelics and brain changes.
The video cites a study of 20 healthy volunteers given 75 micrograms of LSD who reportedly scored higher on optimism, openness, and creativity two weeks later. It also references patients facing death anxiety from life-threatening illness, who reportedly showed reduced anxiety and improved quality of life 12 months after treatment. These findings are presented as early rather than settled.
The video briefly notes microdosing, taking roughly a tenth of a recreational dose for alertness and creativity without hallucinations, while flagging a lack of rigorous research behind the trend. It describes LSD as non-addictive and, per the researchers it cites, less dangerous than drugs like cocaine or heroin, but names real downsides: bad trips involving fear, paranoia, or panic, flashbacks, and rare cases of hallucinogen persisting perception disorder. It also notes that fears linking psychedelic use to psychosis or suicide risk may be overstated, pointing to a US survey where past psychedelic users showed no increased rates of psychosis, depression, or suicide attempts. See Psylopedia's safety and harm reduction guide for a fuller picture.
More videos